Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$4.7 - $9.87 $418 - $878
-89 Reduced 11.87%
661 $4,000
Q3 2023

Nov 09, 2023

BUY
$9.14 - $12.85 $3,619 - $5,088
396 Added 111.86%
750 $8,000
Q2 2023

Aug 11, 2023

SELL
$12.09 - $15.0 $15,305 - $18,990
-1,266 Reduced 78.15%
354 $4,000
Q1 2023

May 11, 2023

BUY
$12.99 - $16.48 $21,043 - $26,697
1,620 New
1,620 $23,000
Q1 2022

May 13, 2022

BUY
$24.46 - $40.92 $1,932 - $3,232
79 New
79 $3,000
Q4 2021

Feb 14, 2022

SELL
$35.0 - $45.94 $8,085 - $10,612
-231 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$36.8 - $60.62 $8,500 - $14,003
231 New
231 $11,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $687M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Loomis Sayles & CO L P Portfolio

Follow Loomis Sayles & CO L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.